Meaning, triple‐vessel CAD was more common in patients having a lower percentage of classical CD14++CD16− and intermediate CD14++CD16+ monocytes and a higher percentage of non‐classical CD14+CD16++ monocytes (Table 1). This evidence concerns the gene CD14 and coronary artery disorder.